AKT1 and cancer: IDO1 and KPM (kynurenine-derived metabolites) have been shown by Bishnupuri et al. to work in concert to stimulate the Phosphoinositide 3-kinase (PI3K)–protein kinase B (AKT) axis, which, in turn, promotes cell proliferation and contributes to the development of cancer.